IL-17A signaling in colonic epithelial cells inhibits pro-inflammatory cytokine production by enhancing the activity of ERK and PI3K

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Guo, Xiaoqin ^a,b   Jiang, Xingwei ^a   Xiao, Yan ^c   Zhou, Tingting ^a   Guo, Yueling ^c   Wang, Renxi ^a   Zhao, Zhi ^a   Xiao, He ^a   Hou, Chunmei ^a   Ma, Lingyun ^c   Lin, Yanhua ^a   Lang, Xiaoling ^a   Feng, Jiannan ^a   Chen, Guojiang ^a   Shen, Beifen ^a   Han, Gencheng ^a   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 12P35; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANDROSTANE DERIVATIVE; CYTOKINE; NITRILE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRAF3IP2 PROTEIN, MOUSE; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; COLONIC EPITHELIAL CELL; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH1 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; COCULTURE; COLON; HT 29 CELL LINE; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANDROSTADIENES; ANIMALS; BUTADIENES; CHEMOKINE CXCL11; COCULTURE TECHNIQUES; COLITIS; COLON; CYTOKINES; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HT29 CELLS; HUMANS; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-17; MICE, INBRED BALB C; NITRILES; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896139923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089714     Document Type: Article

References (43)

1. Strober W, Fuss I, Mannon P (2007) The fundamental basis of inflammatory bowel disease. J Clin Invest 117: 514-521. (Pubitemid 46348505)
2. Kaser A, Zeissig S, Blumberg RS (2010) Inflammatory bowel disease. Annu. Rev. Immunol 28: 573-621.
3. Romagnani S (1999) Th1/Th2 cells Inflamm Bowel Dis 5(4):285-294.
4. Funakoshi K, Sugimura K, Sasakawa T, Bannai H, Anezaki K, et al (1995) Study of cytokines in ulcerative colitis. J Gastroenterol. 30 Suppl 8:61-63.
5. Schreiber S, Rutgeerts P, Fedorak RN, Khaliq-Kareemi M, Kamm MA, et al (2005) A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. Gastroenterology 3: 807-818. (Pubitemid 41242673)
6. Rahimi R, Nikfar S, Abdollahi M (2007) Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials. Biomed. Pharmacother. 1: 75-80. (Pubitemid 46185874)
7. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141. (Pubitemid 41541791)
8. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, et al (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1beta and TNF-alpha, by human macrophages. J. Immunol. 160: 3513-3521. (Pubitemid 28164746)
9. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183:2593-2603. (Pubitemid 26193037)
10. Awane M, Andres PG, Li DJ, Reinecker HC (1999) NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 162: 5337-5344. (Pubitemid 29307140)
11. Onishi RM, Gaffen SL (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129: 311-321.
12. Hueber W, Pate DD, Dryja T, Wright AM, Koroleva I, et al (2010) Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. 2: 52ra72.
13. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, et al (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65-70. (Pubitemid 36020767)
14. Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles CH, et al (2009) Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 58:1629-1636.
15. Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, et al (2012) Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 61(12):1693-1700.
16. Lee JW, Wang P, Kattah MG, Youssef S, Steinman L, et al (2008) Differential regulation of chemokines by IL-17 in colonic epithelial cells. J. Immunol. 181: 6536-6545.
17. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279. (Pubitemid 44498362)
18. O'Connor W, Kamanaka M, Booth CJ, Town T, Nakae S, et al (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10: 603-609.
19. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF et al (2007) The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256. (Pubitemid 46745374)
20. Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, et al (2004) Functional cooperation between interleukin-17 and tumor necrosis factor-α is mediated by CCAAT/enhancer binding protein family members. J. Biol.Chem. 279: 2559-2567. (Pubitemid 38114241)
21. Huang F, Kao CY, Wachi S, Thai P, Ryu J, et al (2007) Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J. Immunol. 179: 6504-6513.
22. Shi F, Guo X, Jiang X, Chen G, Zhou P, et al (2012) Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis. Clinical. Immunology. 145: 230-240.
23. Lytle C, Tod TJ, Vo KT, Lee JW, Atkinson RW, et al (2005) The peroxisome proliferator-activated receptor γ ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm. Bowel. Dis. 11: 231-243. (Pubitemid 40439677)
24. Neurath MF, Fuss I, Kelsall BL, StiJber ER, Strober W (1995) Antibodies to IL-12 abrogate established experimental colitis in mice.J. Exp. Med. 182:1281-1290.
25. Li X, Chen G, Li Y, Wang R, Wang L, et al (2010) Involvement of T Cell Ig Mucin-3 (Tim-3) in the Negative Regulation of Inflammatory bowel diseases. Clin Immunol. 134:169-177;
26. Lefrançois L, Lycke N (2001) Isolation of mouse small intestinal, intraepithelial lymphocytes, Peyer's Patch, and lamina propria cells. Curr. Protoc. Immunol. 3.19.1-3.19.16.
27. Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, et al (2008) Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem. Biophys. Res. Commun. 377: 12-16.
28. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y (2004) Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110: 55-62. (Pubitemid 38177420)
29. Yang XO, Chang SH, Park H, Nurieva R, Shah B, et al (2008) Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205: 1063-1075. (Pubitemid 351679682)
30. Pallone F, Fais S, Capobianchi MR (1988) HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin. Exp. Immunol. 74: 75-79. (Pubitemid 18260915)
31. Hansen JJ, Holt L, Sartor RB (2009) Gene expression patterns in experimental colitis in IL-10 deficient mice. Inflamm. Bowel. Dis. 15: 890-899.
32. Bonnechi RG, Bianchi PP, Bordignon DD (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s, J. Exp. Med, 187(1): 129-134.
33. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, et al (1998) Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3, J. Exp. Med, 187(12): 2009-2021. (Pubitemid 28285570)
34. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, et al (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol. 177(1):36-39 (Pubitemid 43939112)
35. Yamada S, Naito Y, Takagi T, Mizushima K, Hirai Y, et al (2011) Reduced small-intestinal injury induced by indomethacin in interleukin-17A-deficient mice. J Gastroenterol Hepatol.; 26(2):398-404.
36. Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9: 556-576.
37. Kollet J, Witek C, Gentry JD, Liu X, Schwartzbach SD, et al (2001) Deletional analysis of the murine IL-12 p35 promoter comparing IFN- g and lipopolysaccharide stimulation. J. Immunol. 167: 5653-5663. (Pubitemid 33062755)
38. Shen F, Li N, Gade P, Kalvakolanu DV, Weibley T, et al (2009) IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci. Signal. 2 :ra8.
39. Wang Q, Kim S, Wang X, Evers BM (2000) Activation of NF-κB binding in HT-29 colon cancer cells by inhibition of phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 273:853-858. (Pubitemid 30481043)
40. van Dop WA, Marengo S, te Velde AA, Ciraolo E, Franco I, et al (2010) The absence of functional PI3Kγ prevents leukocyte recruitment and ameliorates TNBS-induced colitis in mice. Immunol. Lett. 131: 33-39.
41. Ueno N, Fujiya M, Segawa S, Nata T, Moriichi K, et al (2011) Heat-killed Body of Lactobacillus brevis SBC8803 Ameliorates Intestinal Injury in a Murine Model of Colitis by Enhancing the Intestinal Barrier Function. Inflamm Bowel Dis 17: 2235-2250
42. Pallone F, Fais S, Capobianchi MR (1988) HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli, Clin Exp Immunol, 74(1):75-79. (Pubitemid 18260915)
43. Brandtzaeg P, Halstensen TS, Huitfeldt HS, Krajci P, Kvale D, et al (1992) Epithelial expression of HLA, secretory component (poly-Ig receptor), and adhesion molecules in the human alimentary tract. Ann N Y Acad Sci. 664:157-179. (Pubitemid 23022847)